Use of intravenous immunoglobulin in Lambert-Eaton myasthenic syndrome.

Abstract

The authors report a case of a 65-year-old woman with small cell lung cancer who had profound, progressive lower extremity weakness, intermittent blurred vision, a dry mouth, and orthostatic hypotension. Results of laboratory and electrodiagnostic studies were consistent with the diagnosis of Lambert-Eaton myasthenic syndrome. The patient was treated with one course of intravenous immunoglobulin and had significant improvement.

• Authors: B Lee Peterlin, William Flood, Milind J Kothari
• Journal: The Journal of the American Osteopathic Association (J Am Osteopath Assoc) Vol. 102 Issue 12 Pg. 682-4 (Dec 2002) ISSN: 0098-6151 [Print] United States
• PMID: 12501987 (Publication Type: Case Reports, Journal Article)

Chemical References

• Immunoglobulins, Intravenous

Topics

• Action Potentials
• Aged
• Carcinoma, Small Cell (complications)
• Female
• Humans
• Immunoglobulins, Intravenous (therapeutic use)
• Lambert-Eaton Myasthenic Syndrome (complications, drug therapy, physiopathology)
• Lung Neoplasms (complications)
• Median Nerve (physiopathology)